These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8848817)

  • 1. Relationship between plasma and saliva quinine levels in humans.
    Babalola CP; Bolaji OO; Ogunbona FA; Dixon PA
    Ther Drug Monit; 1996 Feb; 18(1):30-3. PubMed ID: 8848817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of quinine in plasma, red blood cells and saliva after oral and intravenous administration to healthy adult Africans.
    Salako LA; Sowunmi A
    Eur J Clin Pharmacol; 1992; 42(2):171-4. PubMed ID: 1618248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dose size on the pharmacokinetics of orally administered quinine.
    Sowunmi A; Salako LA
    Eur J Clin Pharmacol; 1996; 49(5):383-6. PubMed ID: 8866633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grapefruit juice has no effect on quinine pharmacokinetics.
    Ho PC; Chalcroft SC; Coville PF; Wanwimolruk S
    Eur J Clin Pharmacol; 1999 Jul; 55(5):393-8. PubMed ID: 10456490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of quinine in plasma after a single oral and intramuscular dose in healthy adult Africans.
    Sowunmi A
    East Afr Med J; 1996 Feb; 73(2):111-4. PubMed ID: 8756050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the grapefruit flavonoid naringin on pharmacokinetics of quinine in rats.
    Zhang H; Wong CW; Coville PF; Wanwimolruk S
    Drug Metabol Drug Interact; 2000; 17(1-4):351-63. PubMed ID: 11201303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cigarette smoking enhances the elimination of quinine.
    Wanwimolruk S; Wong SM; Coville PF; Viriyayudhakorn S; Thitiarchakul S
    Br J Clin Pharmacol; 1993 Dec; 36(6):610-4. PubMed ID: 12959282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral quinine pharmacokinetics and dietary salt intake.
    Newton P; Simpson A; Wanwimolruk S; Maliakal P; Villegas L; Kuypers D; White NJ
    Eur J Clin Pharmacol; 2001 May; 57(2):111-3. PubMed ID: 11417441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excretion of proguanil in human saliva.
    Onyeji CO; Ogunbona FA; Dixon PA
    J Pharm Pharmacol; 1989 Dec; 41(12):872-3. PubMed ID: 2576454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinine pharmacokinetics: ototoxic and cardiotoxic effects in healthy Caucasian subjects and in patients with falciparum malaria.
    Claessen FA; van Boxtel CJ; Perenboom RM; Tange RA; Wetsteijn JC; Kager PA
    Trop Med Int Health; 1998 Jun; 3(6):482-9. PubMed ID: 9657511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absolute bioavailability of quinine formulations in Nigeria.
    Babalola CP; Bolaji OO; Ogunbona FA; Ezeomah E
    Afr J Med Med Sci; 2004 Sep; 33(3):185-9. PubMed ID: 15819461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism and elimination of quinine in healthy volunteers.
    Mirghani RA; Hellgren U; Bertilsson L; Gustafsson LL; Ericsson O
    Eur J Clin Pharmacol; 2003 Sep; 59(5-6):423-7. PubMed ID: 12920491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of quinine in obesity.
    Viriyayudhakorn S; Thitiarchakul S; Nachaisit S; Ho PC; Wanwimolruk S
    Trans R Soc Trop Med Hyg; 2000; 94(4):425-8. PubMed ID: 11127249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of quinine in chronic liver disease.
    Auprayoon P; Sukontason K; Na-Bangchang K; Banmairuroi V; Molunto P; Karbwang J
    Br J Clin Pharmacol; 1995 Nov; 40(5):494-7. PubMed ID: 8703656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of quinine in patients with chronic renal failure.
    Rimchala P; Karbwang J; Sukontason K; Banmairuroi V; Molunto P; Na-Bangchang K
    Eur J Clin Pharmacol; 1996; 49(6):497-501. PubMed ID: 8706776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is quinine a suitable probe to assess the hepatic drug-metabolizing enzyme CYP3A4?
    Wanwimolruk S; Paine MF; Pusek SN; Watkins PB
    Br J Clin Pharmacol; 2002 Dec; 54(6):643-51. PubMed ID: 12492613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on the absolute bioavailability of quinine and theophylline from tablets after single dose oral administration as compared to intravenous infusion in healthy male non-smoking volunteers.
    Fuder H; Herzog R; Vaupel W; Wetzelsberger N; Lücker PW
    Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):651-60. PubMed ID: 7746027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinine unbound concentration is the best marker for therapeutic drug monitoring.
    de Pablos-Martinez C; Porte L; Fraissinet F; Berry A; Séraissol P; Lavit M; Chatelut E; Concordet D; Gandia P
    Therapie; 2016 Oct; 71(5):487-489. PubMed ID: 27203159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of quinine and its metabolites in pregnant Sudanese women with uncomplicated Plasmodium falciparum malaria.
    Abdelrahim II; Adam I; Elghazali G; Gustafsson LL; Elbashir MI; Mirghani RA
    J Clin Pharm Ther; 2007 Feb; 32(1):15-9. PubMed ID: 17286785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between plasma and red blood cell concentrations of quinine in Brazilian children with uncomplicated Plasmodium falciparum malaria on oral therapy.
    Vieira JL; Gomes AL; Borges LM; Guimarães ER
    Rev Inst Med Trop Sao Paulo; 2009; 51(2):109-10. PubMed ID: 19390740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.